Clinical trial

Skipping Hormone Therapy in Low-Risk Early Breast Cancer

NCT07661927

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-06

PhasePHASE2

Study timeline

Study start (actual)2026-07-06Date precision: day

Registry last updated2026-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer (Early Breast Cancer)unresolved

Interventions

Removing Endocrine TherapyDRUG

Sponsors & collaborators

UNICANCERlead sponsor

Swiss Cancer Institutecollaborator

Mapped research locations

ParisFrance2 MarseilleFrance2 LyonFrance2 BordeauxFrance2 ToulouseFrance1 StrasbourgFrance1 LilleFrance1 RennesFrance1 NiceFrance1 DijonFrance1 Clermont-FerrandFrance1 CaenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07661927 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.